Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
European house dust mite extract, Quantity: 10 IR/mL
Stallergenes Australia Pty Ltd
European house dust mite extract
Injection, suspension
Excipient Ingredients: mannitol; aluminium hydroxide hydrate; sodium hydroxide; phenol; water for injections
Subcutaneous
Composite pack containing 3 vials: 1 each of 0.1 IR/mL, 1.0 IR/mL, 10.0 IR/mL
(S4) Prescription Only Medicine
Treatment of patients with Type 1 allergy (Gell and Coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.
Visual Identification: Clear and colourless solution.;
Licence status A
2006-10-03